Evidence map›Paper›PMID 42506936›Full record

ArticleJournal of clinical microbiology2026

Head-to-head evaluation of host blood biomarkers for point-of-care TB triage: diagnostic accuracy study.

Kevin Komakech, Ivan Sserwadda, James Sserubiri, Moses Joloba, Grant Theron, Frank Cobelens, Willy Ssengooba

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kevin KomakechDepartment of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID 0009-0009-2141-8696
Ivan SserwaddaDepartment of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres, Amsterdam, Netherlands.
James SserubiriDepartment of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Moses JolobaDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Grant TheronDepartment of Science and Technology-National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-9216-2415
Frank CobelensDepartment of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres, Amsterdam, Netherlands.
Willy SsengoobaDepartment of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID 0000-0002-1643-110X

Funding

European and Developing Countries Clinical Trials Partnership RIA2020I-3305Mr. Willem BakhuysRoozeboom Foundation 2022-7
6 · The paper itself

Abstract

Global tuberculosis (TB) incidence is slowly decreasing, partly because undiagnosed TB continues to fuel transmission. Point-of-care TB triage tests (TTTs) performed near a patient or at the site of patient care may help bridge this gap, but head-to-head comparisons of different host blood biomarkers within the same cohort are limited. In ambulatory adults in Uganda aged ≥15 years with any cough, fever, weight loss, or night sweats, we evaluated the diagnostic accuracy of C-reactive protein (CRP), monocyte-to-lymphocyte ratio (MLR), interferon-gamma-induced protein 10 (IP-10), and hemoglobin (anemia) head-to-head using a reference standard comprised of culture and/or Xpert MTB/RIF Ultra. Cut-offs of CRP and anemia were from World Health Organization (WHO) recommendations, MLR from the literature, and IP-10 from Youden's index. We included 623 participants (193 people living with HIV [PLWHIV]), of whom 111 (18%) were reference standard-positive. Sensitivity and specificity (95% CI) were 91% (84%-96%) and 78% (74%-81%) for CRP (≥10 mg/L); 72% (63%-78%) and 80% (77%-84%) for MLR (≥0.378); 86% (79%-92%) and 73% (69%-77%) for IP-10 (≥28.75); 69% (60%-78%) and 76% (72%-80%) for anemia (<12 g/dL [female], <13 g/dL [male]), respectively. At 90% sensitivity, specificity was 76% (58%-83%) for CRP; 62% (47%-74%) for MLR; 64% (47%-75%) for IP-10, and 28% (17%-51%) for anemia. There was no significant difference for any of the four TTTs in diagnostic odds ratio between participants with and without a history of previous TB, between smokers and non-smokers, and between males and females. However, MLR performed significantly (

Indexed as

BiomarkersPoint-of-Care SystemsTriageTuberculosisAdolescentAdultAnemiaChemokine CXCL10C-Reactive ProteinFemaleHemoglobinsHIV InfectionsHumansMaleMiddle AgedRapid Diagnostic TestsBiomarkersChemokine CXCL10C-Reactive ProteinHemoglobinsdiagnostic accuracy studyhost blood protein biomarkerspoint-of-care TB triagetuberculosis

Identifiers

PMID42506936
PMCPMC13464034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.